“ABC deeply appreciates SFI’s excellent support of ABC’s unique nonprofit educational mission with this adoption of bacopa,” said Mark Blumenthal, founder and executive director of ABC. “As a research-based herbal products company, SFI understands the important role that human clinical research plays in the responsible development of herbal medicinal products.”
The adoption helps ABC maintain its information-rich HerbMedPro database, keeping it up-to-date with the latest scientific and clinical research on this traditional herb on which a growing body of modern scientific and clinical research documents potential health benefits.
HerbMedPro is a comprehensive interactive database available on ABC’s website that provides access to important scientific and clinical research data underlying the use of approximately 250 herbs and their effects on human health.
Also known as brahmi and water hyssop, bacopa (Bacopa monnieri, Plantaginaceae) is a creeping perennial medicinal plant native to India with a long history of use in the Ayurvedic traditional medicine system. It is known primarily for enhancing cognitive ability and brain function as well as its mild sedative effects.
Bacopa contains bacosides, which possess antioxidant activities, and saponins. Other conditions which may benefit from bacopa supplementation include anxiety, depression, and attention deficit hyperactivity disorder.